Archive

Neovasc Announces Third Quarter Financial Results

VANCOUVER and MINNEAPOLIS - (NewMediaWire) - November 05, 2020 - Neovasc, Inc.(NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, and minimally invasive devices for the treatment of refractory angina, today reported financial...

Read More

Neovasc to Report Third Quarter Financial Results on November 5, 2020

VANCOUVER and MINNEAPOLIS - (NewMediaWire) - October 22, 2020 - Neovasc, Inc.(NASDAQ,TSX: NVCN) today announced that it will report financial results for the quarter ended September 30, 2020 after the market close on November 5, 2020. Neovasc President and Chief Executive Officer Fred Colen, and...

Read More

Neovasc to Participate in H.C. Wainwright & Co. 22nd Annual Global Investment Conference

VANCOUVER and MINNEAPOLIS - (NewMediaWire) - September 08, 2020 - Neovasc, Inc.("Neovasc" or the "Company") (NASDAQ,TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, and minimally invasive devices for the treatment of refractory angina, today announced that its management team will be participating...

Read More

Neovasc Announces Partial Prepayment of Convertible Debenture

VANCOUVER and MINNEAPOLIS, MN - (NewMediaWire) - August 17, 2020 - Neovasc Inc. (Neovasc or the Company) (NASDAQ, TSX: NVCN) announced today that Strul Medical Group LLC (SMG) exercised 501,000 of the remaining 1,149,910 common share purchase warrants (the May Warrants) issued pursuant to a...

Read More